IP Library › Granted Patent US 7,090,997
Granted Patent B2
US 7,090,997 · App. 10/415,503 · Granted Aug 15, 2006

Diagnostic agent and test method for colon cancer using tannase as index

Assignee: Eisai Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,090,997
App. No.
10/415,503
Granted
Aug 15, 2006
Kind
B2
Abstract

A diagnostic agent for colon cancer, which comprises a reagent for detecting a tannase high-producing bacterium or measuring an amount of tannase contained in an intracolonic microflora sample, and a test method for colon cancer, which comprises the step of detecting a tannase high-producing bacterium or measuring an amount of tannase contained in an intracolonic microflora sample.

Claims (1)

1. A test method for colon cancer, which comprises the step of detecting Staphylococcus lugdunensis contained in an intracolonic microflora sample.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019235/0487 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 28, 2003
From: SASATSU, MASANORI; NOGUCHI, MASAHISA; SHIRATORI, TAISEI
To: EISAI CO., LTD.
Reel/Frame 014940/0397 →
Priority Claims (1)
JP 2000-326839 · Oct 26, 2000 · national
Continuity (1)
Related Publication 20040137549A1 · Jul 15, 2004